NewEdge Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.79K Buy
212
+6
+3% +$135 ﹤0.01% 3734
2026
Q1
$4.65K Hold
206
﹤0.01% 3615
2025
Q4
$4.91K Hold
206
﹤0.01% 3687
2025
Q3
$5.43K Hold
206
﹤0.01% 3506
2025
Q2
$5.89K Buy
206
+4
+2% +$107 ﹤0.01% 3368
2025
Q1
$5.03K Hold
202
﹤0.01% 3298
2024
Q4
$4.58K Hold
202
﹤0.01% 3261
2024
Q3
$4.3K Sell
202
-9
-4% -$177 ﹤0.01% 3200
2024
Q2
$4.03K Buy
211
+13
+7% +$265 ﹤0.01% 3162
2024
Q1
$3.82K Buy
+198
New +$3.92K ﹤0.01% 3232
2023
Q4
Sell
-34,944
Closed -$753K 3788
2023
Q3
$753K Sell
34,944
-2,960
-8% -$71.9K 0.01% 992
2023
Q2
$907K Sell
37,904
-7,192
-16% -$165K 0.01% 916
2023
Q1
$959K Buy
45,096
+44,484
+7,269% +$852K 0.01% 793
2022
Q4
$8.37K Buy
+612
New +$9.07K ﹤0.01% 2426

Other funds holding FMS

NewEdge Advisors's FMS Position: Q2 2026 in Review

NewEdge Advisors increased its Fresenius Medical Care (FMS) stake by 2.9% in Q2 2026, buying an estimated $135 and bringing the position to 212 shares worth $4.79K. The position accounts for ﹤0.01% of the portfolio, ranked #3734.

NewEdge Advisors first reported a position in FMS in Q4 2022 and has held it in 14 quarters since. The position peaked at $959K in Q1 2023. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • NewEdge Advisors held 212 shares of Fresenius Medical Care worth $4.79K as of Q2 2026.
  • NewEdge Advisors bought 6 Fresenius Medical Care shares in Q2 2026, an estimated $135.
  • Fresenius Medical Care made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3734 holding.
  • NewEdge Advisors first reported a position in Fresenius Medical Care in Q4 2022 and has held it in 14 quarters since.
  • NewEdge Advisors's Fresenius Medical Care position peaked at $959K in Q1 2023.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.